Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_assertion type Assertion NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_head.
- NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_assertion description "[Treatment of ovarian cancer HEY cells with 500 nM 5alpha-dihydrotestosterone (DHT), but not estradiol-17beta or progesterone, for 60 h down-regulated the expression of mRNA for TGF-beta receptors I and II (TbetaR-I and TbetaR-II), betaglycan, and endoglin but had no effect on TGF-beta1 mRNA levels.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_provenance.
- NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_assertion evidence source_evidence_literature NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_provenance.
- NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_assertion SIO_000772 10706107 NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_provenance.
- NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_assertion wasDerivedFrom befree-2016 NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_provenance.
- NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_assertion wasGeneratedBy ECO_0000203 NP277341.RAJS3Ja8ZNMKtgXC2X6FTNjWfuu-ZTmBZVfvemXWrpFKg130_provenance.